论文部分内容阅读
Astra Zeneca公司生产的阿那曲唑( anastrozole,Arimidex)是一个芳香酶抑制剂。据最新研究报告 ,作为晚期乳腺癌的一线治疗药物 ,其效果比抗雌激素药他莫昔芬好。这是他莫昔芬的治疗地位首次受到挑战。Astra Zeneca公司将根据新的研究数据提交申请 ,以使该药获准成为绝经后妇女
Anastrozole (Arimidex), produced by Astra Zeneca, is an aromatase inhibitor. According to the latest research report, the first-line treatment for advanced breast cancer is better than the anti-estrogen drug tamoxifen. This is the first time that the therapeutic status of tamoxifen has been challenged. Astra Zeneca will submit an application based on new research data so that the drug can be approved as a postmenopausal woman